Literature DB >> 11419513

Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.

V Raman1, J Kim, A Sharkey, T Chatila.   

Abstract

We describe a child with aggressive and protracted Kawasaki disease with coronary aneurysms, myocarditis, pericarditis and valvular insufficiency, despite repeated administration of intravenous immunoglobulin. After a transient response to pulse corticosteroids, his disease ultimately subsided with combination therapy with pulse and high dosage corticosteroids and cyclosporin A. Aggressive immunosuppressive therapy with high dosage corticosteroids and cyclosporin A may be beneficial in patients with refractory Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11419513     DOI: 10.1097/00006454-200106000-00022

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

Review 1.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

2.  Infliximab treatment for pediatric refractory Kawasaki disease.

Authors:  Laura L Blaisdell; Jennifer A Hayman; Adrian M Moran
Journal:  Pediatr Cardiol       Date:  2011-07-20       Impact factor: 1.655

3.  Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.

Authors:  Eisuke Suganuma; Fumio Niimura; Shinichi Matsuda; Toshiko Ukawa; Hideaki Nakamura; Kaori Sekine; Masahiko Kato; Yuji Aiba; Yasuhiro Koga; Kuniyoshi Hayashi; Osamu Takahashi; Hiroyuki Mochizuki
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

4.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

5.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.

Authors:  Yoshihiro Onouchi; Tomohiko Gunji; Jane C Burns; Chisato Shimizu; Jane W Newburger; Mayumi Yashiro; Yoshikazu Nakamura; Hiroshi Yanagawa; Keiko Wakui; Yoshimitsu Fukushima; Fumio Kishi; Kunihiro Hamamoto; Masaru Terai; Yoshitake Sato; Kazunobu Ouchi; Tsutomu Saji; Akiyoshi Nariai; Yoichi Kaburagi; Tetsushi Yoshikawa; Kyoko Suzuki; Takeo Tanaka; Toshiro Nagai; Hideo Cho; Akihiro Fujino; Akihiro Sekine; Reiichiro Nakamichi; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Yusuke Nakamura; Akira Hata
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

6.  Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.

Authors:  Fernanda Falcini; Serena Capannini; Donato Rigante
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-20       Impact factor: 3.054

7.  The use of anticoagulation in pediatric cardiac disease.

Authors:  J R Boris; M A Harris
Journal:  Images Paediatr Cardiol       Date:  2003-07

8.  Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report.

Authors:  Shakeel Shaikh; Sidra Ishaque; Taimur Saleem
Journal:  Cases J       Date:  2009-08-06

Review 9.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

10.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.